{"resourceType": "Group", "meta": {"versionId": "3", "lastUpdated": "2025-07-08T12:28:21.297Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-group"]}, "title": "QUARTET USA Trial Control Group", "status": "active", "useContext": [{"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "ComparatorGroup", "display": "ComparatorGroup"}]}}], "membership": "enumerated", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as", "valueMarkdown": "QUARTET USA Trial Control Group [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375182. Revised 2025-07-08. Available at: https://fevir.net/resources/Group/375182. Computable resource at: https://fevir.net/resources/Group/375182#json."}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Brian S. Alper, MD, MSPH"}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code": "active", "display": "Active"}]}}], "url": "https://fevir.net/resources/Group/375182", "id": "375182", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "375182", "assigner": {"display": "Computable Publishing LLC"}}], "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "characteristic": [{"description": "Enrolled in QUARTET USA Trial", "code": {"text": "Member of"}, "valueReference": {"reference": "Group/372797", "type": "Group", "display": "Enrolled Group for QUARTET USA Trial"}, "exclude": false}, {"description": "Assigned to Control group (exposed to candesartan 8 mg once daily)", "code": {"text": "Exposed to"}, "valueReference": {"reference": "ActivityDefinition/375181", "type": "ActivityDefinition", "display": "Candesartan 8 mg once daily"}, "exclude": false}], "quantity": 30, "combinationMethod": "all-of", "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "type": "person", "description": "This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide."}